19:50 EDT Kazia Therapeutics (KZIA) trading halted, news pending
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KZIA:
- Kazia Therapeutics Announces ADS Ratio Change to Maintain Nasdaq Compliance
- Kazia Therapeutics Sells Cantrixil IP Rights to Vivesto for $1 Million
- Kazia Therapeutics sells IP, trademarks rights to Cantrixil for $1M
- Kazia Therapeutics Advances Cancer Drug Development with Strategic Moves and Promising Trial Results
- Kazia Therapeutics: Buy Rating Driven by Dual Potential in GBM and Parkinson’s Disease